RYAN SZENDERSKI: Open Payments
NPI 1053538512 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,512 in 142 payments from 28 companies in 2025. Trend: 2023 $1,328 · 2024 $2,264 · 2025 $2,512
Food & beverage: $2,452Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $298 |
| ABBVIE INC. | 16 | $281 |
| Novo Nordisk Inc | 16 | $239 |
| Amgen Inc. | 14 | $195 |
| PFIZER INC. | 8 | $160 |
| Axsome Therapeutics, Inc. | 6 | $149 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101 |
| Kowa Pharmaceuticals America, Inc. | 7 | $99 |
| Lilly USA, LLC | 6 | $95 |
| Astellas Pharma US Inc | 3 | $94 |
Products named: Ozempic, AIRSUPRA, Auvelity, NURTEC ODT, OTEZLA, REXULTI, UBRELVY, XIFAXAN.
Industry payments across OH — which companies pay providers there.
